167 related articles for article (PubMed ID: 23073704)
1. Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.
Chen D; Roda JM; Marsh CB; Eubank TD; Friedman A
Bull Math Biol; 2012 Nov; 74(11):2752-77. PubMed ID: 23073704
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
Roda JM; Sumner LA; Evans R; Phillips GS; Marsh CB; Eubank TD
J Immunol; 2011 Aug; 187(4):1970-6. PubMed ID: 21765015
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model.
Roda JM; Wang Y; Sumner LA; Phillips GS; Marsh CB; Eubank TD
J Immunol; 2012 Sep; 189(6):3168-77. PubMed ID: 22869907
[TBL] [Abstract][Full Text] [Related]
4. Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes.
Eubank TD; Roda JM; Liu H; O'Neil T; Marsh CB
Blood; 2011 Jan; 117(1):323-32. PubMed ID: 20952691
[TBL] [Abstract][Full Text] [Related]
5. Melanoma exosome induction of endothelial cell GM-CSF in pre-metastatic lymph nodes may result in different M1 and M2 macrophage mediated angiogenic processes.
Hood JL
Med Hypotheses; 2016 Sep; 94():118-22. PubMed ID: 27515216
[TBL] [Abstract][Full Text] [Related]
6. Modeling the inhibition of breast cancer growth by GM-CSF.
Szomolay B; Eubank TD; Roberts RD; Marsh CB; Friedman A
J Theor Biol; 2012 Jun; 303():141-51. PubMed ID: 22763136
[TBL] [Abstract][Full Text] [Related]
7. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2013; 19():1-15. PubMed ID: 23335846
[TBL] [Abstract][Full Text] [Related]
8. HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularization.
Noguera R; Fredlund E; Piqueras M; Pietras A; Beckman S; Navarro S; Påhlman S
Clin Cancer Res; 2009 Dec; 15(23):7130-6. PubMed ID: 19903792
[TBL] [Abstract][Full Text] [Related]
9. Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
Varney ML; Olsen KJ; Mosley RL; Singh RK
J Interferon Cytokine Res; 2005 Nov; 25(11):674-83. PubMed ID: 16318581
[TBL] [Abstract][Full Text] [Related]
10. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
[TBL] [Abstract][Full Text] [Related]
11. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
Nilsson MB; Zage PE; Zeng L; Xu L; Cascone T; Wu HK; Saigal B; Zweidler-McKay PA; Heymach JV
Oncogene; 2010 May; 29(20):2938-49. PubMed ID: 20208561
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
13. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.
Blancher C; Moore JW; Talks KL; Houlbrook S; Harris AL
Cancer Res; 2000 Dec; 60(24):7106-13. PubMed ID: 11156418
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 and granulocyte-macrophage colony-stimulating factor mediates the upregulation of soluble vascular endothelial growth factor receptor-1 in RAW264.7 cells-a process in which p38 mitogen-activated protein kinase signaling has an important role.
Xia L; Dong Z; Zhang Y; Zhang X; Song X; Sun M; Hu Y; Liu S; Wang K; Qu X; Wei F
J Microbiol Immunol Infect; 2016 Jun; 49(3):344-51. PubMed ID: 25132397
[TBL] [Abstract][Full Text] [Related]
15. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
[TBL] [Abstract][Full Text] [Related]
16. Reshaping of Human Macrophage Polarization through Modulation of Glucose Catabolic Pathways.
Izquierdo E; Cuevas VD; Fernández-Arroyo S; Riera-Borrull M; Orta-Zavalza E; Joven J; Rial E; Corbi AL; Escribese MM
J Immunol; 2015 Sep; 195(5):2442-51. PubMed ID: 26209622
[TBL] [Abstract][Full Text] [Related]
17. Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis.
Lee SJ; Kim HP; Jin Y; Choi AM; Ryter SW
Autophagy; 2011 Aug; 7(8):829-39. PubMed ID: 21685724
[TBL] [Abstract][Full Text] [Related]
18. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factors promote alveolar development and regeneration.
Vadivel A; Alphonse RS; Etches N; van Haaften T; Collins JJ; O'Reilly M; Eaton F; Thébaud B
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):96-105. PubMed ID: 23962064
[TBL] [Abstract][Full Text] [Related]
20. Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.
Takeda N; O'Dea EL; Doedens A; Kim JW; Weidemann A; Stockmann C; Asagiri M; Simon MC; Hoffmann A; Johnson RS
Genes Dev; 2010 Mar; 24(5):491-501. PubMed ID: 20194441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
